Momento Tecnologia #144: Derivados de eugenol para medicamentos contra a leishmaniose episode artwork

EPISODE · Mar 3, 2026 · 6 MIN

Momento Tecnologia #144: Derivados de eugenol para medicamentos contra a leishmaniose

from Momento Tecnologia - USP · host Jornal da USP

Com média anual de 12.655 casos, a leishmaniose afeta principalmente regiões rurais no Norte e Nordeste do País

Com média anual de 12.655 casos, a leishmaniose afeta principalmente regiões rurais no Norte e Nordeste do País

NOW PLAYING

Momento Tecnologia #144: Derivados de eugenol para medicamentos contra a leishmaniose

0:00 6:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Autoengaños

Jun 18, 2026 ·25m

El video de Apple

Jun 10, 2026 ·25m

El amigo americano

Jun 7, 2026 ·19m

Falsos profetas

May 20, 2026 ·15m

MINISFORUM MS-A2

May 9, 2026 ·26m

Frequently Asked Questions

How long is this episode of Momento Tecnologia - USP?

This episode is 6 minutes long.

When was this Momento Tecnologia - USP episode published?

This episode was published on March 3, 2026.

What is this episode about?

Com média anual de 12.655 casos, a leishmaniose afeta principalmente regiões rurais no Norte e Nordeste do País

Can I download this Momento Tecnologia - USP episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!